How does Cronos Group Inc. (CRON) change from a tortoise to a hare?

Cronos Group Inc. (NASDAQ: CRON) stock jumped 3.93% on Friday to $3.17 against a previous-day closing price of $3.05. With 1.87 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.12 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.1900 whereas the lowest price it dropped to was $3.0200. The 52-week range on CRON shows that it touched its highest point at $6.95 and its lowest point at $2.57 during that stretch. It currently has a 1-year price target of $4.59. Beta for the stock currently stands at 1.45.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRON was down-trending over the past week, with a drop of -7.04%, but this was up by 1.60% over a month. Three-month performance surged to 2.59% while six-month performance fell -19.54%. The stock lost -52.26% in the past year, while it has lost -19.13% so far this year. A look at the trailing 12-month EPS for CRON yields -0.37 with Next year EPS estimates of -0.19. For the next quarter, that number is -0.06. This implies an EPS growth rate of -418.00% for this year and 25.00% for next year.

Float and Shares Shorts:

At present, 376.03 million CRON shares are outstanding with a float of 198.01 million shares on hand for trading. On Jul 14, 2022, short shares totaled 13.07 million, which was 3.48% higher than short shares on Jun 14, 2022. In addition to Mr. Michael Ryan Gorenstein J.D. as the firm’s Pres, CEO & Chairman, Mr. Robert L. Madore serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 15.92% of CRON’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of CRON, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 2.87% stake in CRON, the ETFMG Alternative Harvest ETF is the largest stakeholder. A total of 10,779,788 shares are owned by the mutual fund manager. The Horizons Marijuana Life Sciences, which owns about 1.34% of CRON stock, is the second-largest Mutual Fund holder. It holds 5,014,376 shares valued at 15.8 million. Vanguard Total International Stoc holds 0.66% of the stake in CRON, owning 2,489,720 shares worth 7.84 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRON since 12 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 2 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CRON analysts setting a high price target of $7.85 and a low target of $2.64, the average target price over the next 12 months is $4.38. Based on these targets, CRON could surge 147.63% to reach the target high and fall by -16.72% to reach the target low. Reaching the average price target will result in a growth of 38.17% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CRON will report FY 2022 earnings on 05/01/2023. Analysts have provided yearly estimates in a range of -$0.06 being high and -$0.30 being low. For CRON, this leads to a yearly average estimate of -$0.22. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Cronos Group Inc. surprised analysts by $0.01 when it reported -$0.05 EPS against a consensus estimate of -$0.06. The surprise factor in the prior quarter was -$0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.04 and the low estimate is -$0.08. The average estimate for the next quarter is thus -$0.06.

Leave a Comment

Your email address will not be published.